Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) — The “Spatial Genomics and Transcriptomics – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for Spatial Genomics and Transcriptomics was estimated at US$295.0 Million in 2023 and is projected to reach US$561.9 Million by 2030, growing at a CAGR of 9.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the Spatial Genomics and Transcriptomics market is driven by several factors, including increasing demand for advanced tools in genomics research that offer spatial context, critical for understanding complex biological processes. Technological advancements in sequencing methods, imaging, and data analysis have enhanced the accuracy and efficiency of spatial genomics and transcriptomics, supporting broader adoption across research fields. The rise of personalized medicine, which requires detailed insights into tissue-specific gene expression, has further fueled demand, particularly in oncology and drug development. Additionally, government funding, academic collaborations, and pharmaceutical investments in spatial research have contributed to market growth, as researchers aim to uncover new insights into cellular behavior and disease mechanisms.
What Are the Key Segments in the Spatial Genomics and Transcriptomics Market?
Major techniques include spatial transcriptomics, spatial genomics sequencing, and in situ hybridization, with spatial transcriptomics holding the largest market share due to its ability to map gene expression patterns across tissues. Applications cover oncology, neuroscience, developmental biology, and drug discovery, with oncology representing a significant segment driven by the need for precise mapping of tumor microenvironments and personalized medicine approaches. End-users include academic and research institutes, pharmaceutical companies, and diagnostic laboratories, with academic institutes leading the market as they adopt these technologies for in-depth biological research.
How Are Spatial Genomics and Transcriptomics Integrated Across Research Fields?
In oncology, spatial genomics and transcriptomics help researchers understand tumor heterogeneity, immune infiltration, and gene expression patterns within tumors, supporting targeted therapies and precision medicine. In neuroscience, these techniques are used to map gene expression in brain tissues, revealing insights into neural development, connectivity, and neurological disorders. Developmental biology benefits from spatial mapping of gene activity, allowing scientists to study embryonic development, tissue differentiation, and organogenesis. Pharmaceutical companies use spatial genomics and transcriptomics for drug discovery and biomarker identification, enabling the development of targeted therapies based on tissue-specific gene expression.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Spatial Genomics and Transcriptomics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Spatial Genomics and Transcriptomics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Spatial Genomics and Transcriptomics Consumables segment, which is expected to reach US$320.3 Million by 2030 with a CAGR of a 10.0%. The Spatial Genomics and Transcriptomics Instruments segment is also set to grow at 7.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $82.0 Million in 2023, and China, forecasted to grow at an impressive 9.0% CAGR to reach $85.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players in the Global Spatial Genomics and Transcriptomics Market such as 10x Genomics, Advanced Cell Diagnostics, Inc. (ACD), Cartana AB, Dovetail Genomics, Horizon Discovery Group plc and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 89 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $295 Million |
| Forecasted Market Value (USD) by 2030 | $561.9 Million |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Spatial Genomics and Transcriptomics – Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Rising Demand for Single-Cell Analysis Drives Adoption
- Increasing Focus on Personalized Medicine Expands Addressable Market Opportunities
- Technological Advancements in Sequencing Technologies Propel Market Growth
- Rising Investments in Genomics Research Strengthens Business Case for Spatial Analysis
- Increasing Adoption of Spatial Genomics in Drug Discovery Expands Market Potential
- Emergence of High-Throughput Sequencing Platforms Fuels Market Growth
- Rising Use in Biomarker Discovery Generates Opportunities for Spatial Genomics
- Increasing Focus on Spatial Mapping of Gene Expression in Tissue Samples Propels Demand
- Growing Integration of AI and Machine Learning in Spatial Genomics Analysis Drives Growth
- Emergence of Novel Imaging Technologies Expands Market Opportunities
FOCUS ON SELECT PLAYERS:Some of the 33 companies featured in this Global Spatial Genomics and Transcriptomics market report include
- 10x Genomics
- Advanced Cell Diagnostics, Inc. (ACD)
- Cartana AB
- Dovetail Genomics
- Horizon Discovery Group plc
- Illumina, Inc.
- NanoString Technologies,
- Readcoor, inc.
- S2 Genomics, Inc.
- Seven Bridges Genomic
For more information about this report visit https://www.researchandmarkets.com/r/scbv2d
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Spatial Genomics and Transcriptomics Market
